# Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine

> **NCT07416110** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Sinovac Biotech Co., Ltd** · enrollment: 912 (estimated)

## Conditions studied

- Rabies (Healthy Volunteers)

## Interventions

- **BIOLOGICAL:** Sinovac rabies vaccine

## Key facts

- **NCT ID:** NCT07416110
- **Lead sponsor:** Sinovac Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-04
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 912 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07416110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07416110, "Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07416110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*